BMSEED Showcases Stretchable Microelectrode Arrays for Drug Development at the 7th Pharma Science R&D Conference

At the 7th International Conference on Pharma Science Research and Development, held in Burlingame, CA, BioMedical Sustainable Elastic Electronic Devices (BMSEED) presented its latest advancements in stretchable microelectrode arrays designed to enhance microphysiological systems for drug development. The event brought together experts in drug discovery, development, and pre-clinical research, providing a platform for cutting-edge innovations in the pharmaceutical industry.

BMSEED’s presentation, "Enhancing Microphysiological Systems for Drug Development Using Stretchable Microelectrode Arrays," was delivered by Oliver Graudejus, Founder of BMSEED. The research focuses on the development of dynamic, stretchable models to improve the study of Alzheimer’s Disease. Unlike traditional rigid systems, these innovative microelectrode arrays more accurately replicate physiological conditions, offering a transformative approach to pre-clinical testing and drug screening.

By creating a more adaptable and predictive testing system, BMSEED’s technology has the potential to accelerate therapeutic discoveries, particularly in the fight against neurodegenerative diseases. These advancements could lead to more effective treatments, ultimately improving patient outcomes worldwide.

As research progresses, BMSEED remains committed to driving biomedical innovation and expanding the possibilities for next-generation drug development.